IRIS

Sfoglia per Rivista  ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 23
Titolo Data di pubblicazione Autore(i) File
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy 1-gen-2008 Fagotti, A.; Fanfani, F.; Rossitto, C.; Lorusso, D; De Gaetano, A. M.; Giordano, A.; Vizzielli, G.; Scambia, G.
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features 1-gen-2018 Maltese, G; Fontanella, C; Lepori, S; Scaffa, C; Fucà, G; Bogani, G; Provenzano, S; Carcangiu, Ml; Raspagliesi, F; Lorusso, D
Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial 1-gen-2009 Pignata, S.; Scambia, G.; Savarese, A.; Breda, E.; Sorio, R.; Pisano, C.; Lorusso, D; Cognetti, F.; Lombardi A., Vernaglia; Gebbia, V.; Scollo, P.; Morabito, A.; Signoriello, G.; Perrone, F.
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 1-gen-2005 Danova, M; Rigolin, Gm; Brugnatelli, S; Rovati, B; Tronconi, C; Fraulini, C; Russo Rossi, A; Riccardi, A; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors. 1-gen-2009 Insabato, L; Amelio, I; Quarto, M; Zannetti, A; Tolino, F; de Mauro, G; Cerchia, L; Riccio, P; Baumhoer, D; Condorelli, G; Terracciano, L; de Franciscis, V
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram 1-gen-2018 Pietrantonio, F; Barretta, F; Fanotto, V; Park, Sh; Morano, F; Fucà, G; Niger, M; Prisciandaro, M; Silvestris, N; Bergamo, F; Fornaro, L; Bordonaro, R; Rimassa, L; Santini, D; Tomasello, G; Antonuzzo, L; Noventa, S; Avallone, A; Leone, F; Faloppi, L; Di Donato, S; de Braud, F; Lee, J; De Vita, F; Di Bartolomeo, M; Miceli, R; Aprile, G
Final results of a prospective trial of a PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma 1-gen-2005 Reni, M; Passoni, P; Bonetto, E; Balzano, G; Panucci, Mg; Zerbi, A; Ronzoni, M; Staudacher, C; Villa, E; Di Carlo, V
Herpes infections in breast cancer patients treated with adjuvant chemotherapy 1-gen-2006 Masci, G; Magagnoli, M; Gullo, G; Morenghi, E; Garassino, I; Simonelli, M; Santoro, A
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies 1-gen-2014 Lorusso, D; Ratti, M; Ditto, A; Raspagliesi, F
Is Postoperative Computed Tomography Evaluation a Prognostic Indicator in Patients with Optimally Debulked Advanced Ovarian Cancer? 1-gen-2014 Lorusso, D; Sarno, I; Di Donato, V; Palazzo, A; Torrisi, E; Pala, L; Marchiano, A; Raspagliesi, F
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach? 1-gen-2019 Lorusso, D; Martinelli, F; Maltese, G; Fontanella, C; Sabatucci, I; Ditto, A; Signorelli, M; Bogani, G; Lepori, S; Tripodi, E; Pappalardi, B; Scaffa, C; Cerrotta, A; Rapagliesi, F.
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 1-gen-2019 Cavalieri, S.; Perrone, F.; Milione, M.; Bianco, A.; Alfieri, S.; Locati, L. D.; Bergamini, C.; Resteghini, C.; Galbiati, D.; Platini, F.; Licitra, L.; Bossi, P.
Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion 1-gen-1990 Montaldo, P. G.; Figoli, F.; Zanette, M. L.; Sorio, R.; Zucchetti, M.; Tirelli, U.; D'Incalci, M.
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer 1-gen-2002 D'Agostino, G; Ferrandina, G; Garganese, G; Salerno, Mg; Lorusso, D; Farnetano, Mg; Mancuso, S; Scambia, G
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients - May a new treatment schedule improve toxicity profile? 1-gen-2004 Lorusso, D; Naldini, A; Testa, A; D'Agostino, G; Scambia, G; Ferrandina, G
Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer 1-gen-2011 Lorusso, D; Mainenti, S.; Pietragalla, A.; Fusco, E.; Malaguti, P.; Masciullo, V.; Scambia, G.
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 1-gen-2018 De Sanctis, R; Agostinetto, E; Masci, G; Ferraro, E; Losurdo, A; Vigano, A; Antunovic, L; Zuradelli, M; Torrisi, Rmc; Santoro, A
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer 1-gen-2005 Storojeva, I; Boulay, Jl; Ballabeni, P; Buess, M; Terracciano, L; Laffer, U; Mild, G; Herrmann, R; Rochlitz, C.
Short schedule of cisplatin and vinorelbine: A dose-finding study in non-small-cell lung cancer 1-gen-2006 Zucali, Pa; Soto Parra, Hj; Cavina, R; Campagnoli, E; Latteri, F; De Vincenzo, F; Ceresoli, Gl; Fazio, M; Alloisio, M; Santoro, A
Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery 1-gen-2007 Lorusso, D; Ferrandina, G.; Pagano, L.; Gagliardi, M. L.; Scambia, G.
Mostrati risultati da 1 a 20 di 23
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile